warnings about the erythropoietin analogues Eprex (epoetin) and Aranesp (darbepoetin)
January 2007
Read important updated information from the FDA
You'll hear warnings about the erythropoietin analogues Eprex (epoetin) and Aranesp (darbepoetin).
There are reports of increased death and cardiovascular events when these drugs are used to boost hemoglobin above 120 g/L.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote